Evident Vascular announced today that it closed a Series B financing round to support its AI-powered intravascular ultrasound (IVUS) platform.
The San Jose, California-based company did not disclose the amount raised in the Series B round. It adds to $35 million picked up in a Series A that brought the company out of stealth mode in 2023. Founding investor Vensana Capital contributed to the latest funding round. New investors Shangbay Capital and two undisclosed multinational strategics…
Article Source
https://www.massdevice.com/evident-vascular-closes-series-b-ivus/
